251 related articles for article (PubMed ID: 21880491)
1. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
5. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
[TBL] [Abstract][Full Text] [Related]
7. Efficient synthesis and anti-enteroviral activity of 9-arylpurines.
Aguado L; Canela MD; Thibaut HJ; Priego EM; Camarasa MJ; Leyssen P; Neyts J; Pérez-Pérez MJ
Eur J Med Chem; 2012 Mar; 49():279-88. PubMed ID: 22305341
[TBL] [Abstract][Full Text] [Related]
8. Novel substituted 9-norbornylpurines and their activities against RNA viruses.
Sála M; Hřebabecký H; Leyssen P; Dejmek M; Dračínský M; De Palma AM; Neyts J; Nencka R
Bioorg Med Chem Lett; 2012 Mar; 22(5):1963-8. PubMed ID: 22310228
[TBL] [Abstract][Full Text] [Related]
9. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
[TBL] [Abstract][Full Text] [Related]
10. QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
Muratov EN; Varlamova EV; Artemenko AG; Khristova T; Kuz'min VE; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
Future Med Chem; 2011 Jan; 3(1):15-27. PubMed ID: 21428823
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
[TBL] [Abstract][Full Text] [Related]
12. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
13. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists.
Wang YX; Wang L; Xu YN; Li YH; Jiang JD; Si SY; Li YB; Ren G; Shan YQ; Hong B; Song DQ
Eur J Med Chem; 2011 Apr; 46(4):1066-73. PubMed ID: 21295889
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].
Wang YX; Zhao WL; Bi CW; Li YB; Shao RG; Song DQ
Yao Xue Xue Bao; 2012 Feb; 47(2):200-5. PubMed ID: 22512031
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
Pürstinger G; De Palma AM; Zimmerhofer G; Huber S; Ladurner S; Neyts J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5123-5. PubMed ID: 18710805
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities.
Li YP; Shan GZ; Peng ZG; Zhu JH; Meng S; Zhang T; Gao LY; Tao PZ; Gao RM; Li YH; Jiang JD; Li ZR
Antivir Chem Chemother; 2010 Aug; 20(6):259-68. PubMed ID: 20710066
[TBL] [Abstract][Full Text] [Related]
19. 9-Arylpurines as a novel class of enterovirus inhibitors.
Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of halogenated 12N-sulfonyl matrinic butanes as potential anti-coxsackievirus agents.
Cheng XY; Li YH; Tang S; Zhang X; Wang YX; Wang SG; Jiang JD; Li YH; Song DQ
Eur J Med Chem; 2017 Jan; 126():133-142. PubMed ID: 27750147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
